Building Resilient Biomarker Infrastructure: From Pandemic Preparedness to Clinical Testing Excellence
- Accelerating biomarker delivery through integrated assay platforms – how Moderna’s UK Clinical Biomarker Laboratory is enabling rapid, compliant deployment of immunoassay, cytometry, and molecular methods for global clinical programs
- Embedding automation and AI in sample and data workflows – leveraging robotic biobanking, and digital traceability to enhance efficiency, reproducibility, and data integrity
- Pandemic preparedness and translational resilience – establishing high-containment and rapid-assay transfer capabilities to respond to emerging pathogens and future public-health challenges